Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 11,921–11,940 of 17,974 drug recalls

Drug Recall Terminated Historical recordClass II

HYALURONIDASE 500U/ML(PF), 3ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

GERMANIUM SESO 100MG/ML (PF), 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

GABA 50MG/ML (PF), 50ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

FOLIC ACID 10MG/ML W/PRES. (METHYLPARABEN 0.05%, PROPYLPARABEN 0.025% IN NACL, 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

FOLIC ACID 10MG/ML IN NACL (PF), 1ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

ESTRADIOLVAL 3MG/TEST CYP 35MG/ TEST PROP 35MG/ML W/PRES. (BENZYL ETOH 2%), 3ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

EDTA DISODIUM 15% (150MG/ML), 20ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

DMSO 99.9 (PF), In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

DMPS 50MG/ML (PF), 5ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

DEXPANTHENOL 250MG/ML W/PRES. (BENZALKONIUM CHL 0.01%), 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

DEXPANTHENOL 250MG/ML (PF), In a) 2ML Vials and b) 5ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

CESIUM CHLORIDE 600MG/ML (PF), 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

CALCIUM SODIUM EDTA 300MG/ML (PF), 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

B-COMPLEX W/METHYL B12/LIDO W/PRES (BENZYL ETOH 2%), B1-100MG, B2-5-PO4-2MG, B3-50MG, B5-2MG, B6-2MG, LIDOCAINE 1%, METHYL B12 1MG/ML, In a) 1ML Vials, b) 5ML Vials, and c) 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

B-COMPLEX W/CYANO B12 W/PRES., (BENZYL ETOH 2%), B1-100MG, B2-5-PO4-2MG, B3-50MG, B5-2MG, B6-2MG, CYANO B12 1MG/ML, In a) 2ML Vials, b) 5MLVials, c) 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

B-COMPLEX 50 IN NACL 0.9% W/PRES., (BENZYL ETOH 2%), B1-50MG, B2-5-PO4-5MG, B3-50MG, B5-50MG, B6-50MG/ML, 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

B-COMPLEX 50 IN NACL 0.9% (PF) B1-50MG, B2-5-PO4-5MG, B3-50MG, B5-50MG, B6-50MG/ML, 2ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

B-COMPLEX WITHOUT B12 W/PRES (BENZYL ETOH 2%), B1-100MG, B2-5-PO4-2MG, B3-50MG, B5-2MG, B6-2MG/ML, In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

B-COMPLEX WITHOUT B12 (PF) IN NACL 0.9%, B1-100MG, B2-5-PO4-2MG, B3-50MG, B5-2MG, B6-2MG/ML, In a) 2ML Vials and b) 5ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Drug Recall Terminated Historical recordClass II

B-COMPLEX (LIEBERMAN) IN NACL 0.9% (PF), B1-12.5MG, B2-5-PO4-10MG, B3-12.5MG, B5-12.5MG, B6-12.5MG/ML, 2ML Vials, MEDAUS PHARMACY

by Medaus, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
May 13, 2016
Reported by FDA
July 20, 2016
Distribution
U.S. Nationwide, Japan, and New Zealand.

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.